4
Changes in Ownership
Protagenic Therapeutics, Inc.new Filed Acc 0001493152-20-013712
Options or other derivatives
- Chief Financial Officer acquired 124,998 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Arrow Alexander K. Chief Financial Officer | 2020-07-18 | Grant or award · PTIX Common stock Options | +124,998 | $1.75 | $218,747 | 124,998 | D |
Loading xslF345X03/ownership.xml…